These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1617997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S, Guay D, Opsahl J, Tack K, Matzke G.
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [Abstract] [Full Text] [Related]

  • 4. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C, Bouquet S, Breux JP, Becq-Giraudon B, Beauchant M.
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ofloxacin. An overview.
    Flor S.
    Am J Med; 1989 Dec 29; 87(6C):24S-30S. PubMed ID: 2603892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P, Fourtillan JB, Modai J, Couet W, Lefebvre MA, Darchis JP, Vincent Du Laurier M, Bryskier A.
    Pathol Biol (Paris); 1986 Jun 29; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [Abstract] [Full Text] [Related]

  • 8. Ofloxacin pharmacokinetics in chronic renal failure and dialysis.
    Lameire N, Rosenkranz B, Malerczyk V, Lehr KH, Veys N, Ringoir S.
    Clin Pharmacokinet; 1991 Nov 29; 21(5):357-71. PubMed ID: 1773550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP, Leroy A, Borsa-Lebas F, Etienne I, Gy C, Humbert G.
    Drugs Exp Clin Res; 1992 Nov 29; 18(11-12):487-92. PubMed ID: 1308475
    [Abstract] [Full Text] [Related]

  • 11. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R, Müller-Liebenau B, Somogyi A.
    Br J Clin Pharmacol; 1982 Sep 29; 14(3):421-30. PubMed ID: 7126415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L, Sriranjani D, Ramesh S, Sriram P, Mathuram LN.
    J Vet Pharmacol Ther; 2006 Jun 29; 29(3):185-9. PubMed ID: 16669862
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of cirrhosis and renal failure on the kinetics of clotiazepam.
    Ochs HR, Greenblatt DJ, Knüchel M.
    Eur J Clin Pharmacol; 1986 Jun 29; 30(1):89-92. PubMed ID: 2872061
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O.
    Clin Pharmacokinet; 1981 Jun 29; 6(5):375-88. PubMed ID: 7333059
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L, Venuti M, Strazzabosco M, Iemmolo RM, Nassuato G, Orlando R, Lirussi F.
    Acta Physiol Hung; 1984 Jun 29; 64(3-4):393-400. PubMed ID: 6099684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.